“…[16][17][18][19][20][21][22][23][24][25][26] Utilizing them as starting materials either in racemic or enantioenriched form provides access to unique chiral ligands and organocatalysts, as well as more advanced novel PCP derivatives that may show interesting properties (on a longer term perspective). [3,10,[16][17][18][19][20][21][22][23][24][25][26] Importantly, racemic 4-formyl [2.2]paracyclophane 2, [13][14][15] as well as different diformyl [2.2]paracyclophanes, [19] can easily be obtained from 1 and, given their high synthetic value, it comes as no surprise that the development of robust enantioselective (resolution) approaches to access enantioenriched formyl-containing PCPs has attracted considerable attention over the last decades. [16,17,[20][21][22][23][24] As already state above, these compounds, i. e. 4formyl[2.2]paracyclophane 2 (Scheme 1,A), have been utilized for numerous further manipulations.…”